Form 4: Calumet Director Sells 100,000 Shares Under Pre-Arranged Trading Plan

Jennifer Straumins, a Director at Calumet, Inc., sold 100,000 shares of common stock for $13.17 per share on June 5, 2025, as part of a Rule 10b5-1 trading plan.

Summary

• Jennifer Straumins, a Director of Calumet, Inc. (CLMT), reported a transaction involving the company's common stock.
• On June 5, 2025, Ms. Straumins disposed of 100,000 shares of common stock.
• The shares were sold at a price of $13.17 per share.
• Following this transaction, Ms. Straumins directly beneficially owns 1,084,589 shares of Calumet, Inc. common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 4

Explanation: The sale of a significant number of shares by a director, while conducted under a pre-arranged 10b5-1 plan, can still be perceived as a mildly negative signal regarding the insider's view on the stock's future appreciation potential.

Positives

• The transaction was conducted under a Rule 10b5-1(c) plan, indicating it was pre-scheduled and not based on immediate, non-public information, which can mitigate the negative perception of an insider sale.

Negatives

• A director selling a significant number of shares (100,000) can be perceived as a negative signal by investors, potentially suggesting that the insider believes the stock is fully valued or that future growth prospects are limited.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May interpret the director's sale as a negative signal, potentially impacting investor sentiment and the company's stock price.

Key Dates

Recommendation

Keywords

Calumet, CLMT, insider trading, Form 4, director stock sale, Jennifer Straumins, beneficial ownership, SEC filing, Rule 10b5-1